49 publications
Name | Date | Type | Actions |
---|---|---|---|
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (23 au 27 mai 2016) (french) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
30/05/2016 | Monthly communication regarding buyback programs | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mai au 3 juin 2016) - french Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
06/06/2016 | Monthly communication regarding buyback programs | |
Programme de rachat - mai 2016 - french Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/06/2016 | Monthly communication regarding buyback programs | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (20 au 24 juin 2016) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
01/07/2016 | Monthly communication regarding buyback programs | |
Dynamic first half 2016 2016 Half year Financial Report |
28/07/2016 | Public releases | |
Communiqué de mise à disposition du rapport financier semestriel relatif à l’exercice 2016 (french) Communiqué de mise à disposition du rapport financier semestriel relatif à l’exercice 2016 |
28/07/2016 | Public releases | |
Vetoquinol launches its employer brand The veterinary pharmaceutical company Vetoquinol launches its employer brand. For 83 years, Vetoquinol has been building its future, drawing on relationships of trust with its partners, the development of every employee, and its long-held belief of continuous improvement. Following on from its corporate brand, the company is now positioning itself as a high-quality employer. |
29/09/2016 | Public releases | |
September 2016 year-to-date sales: €257.5 million a 4.8% organic growth Vetoquinol posted sales of €257.5 million for the first nine months of 2016, up 2.3% compared to the same period last year. Organic growth for the period came to 4.8%, curbed by a 2.5% negative currency impact. |
18/10/2016 | Public releases | |
2015 sales up 8.7% to €342.6 million The Vetoquinol Group posted 2015 sales of €342.6 million, up 8.7% on reported data and up 3.8% at constant exchange rates. The Group benefited from a positive currency impact of 4.9% mainly linked to the US dollar, Indian rupee and British pound. |
08/02/2016 | Public releases | |
2015 results sales of reference products up 9.4% ebit up 10.3% At its meeting on March 18, 2016, the Vetoquinol S.A. Board of Directors reviewed the Group’s results and approved the 2015 financial statements. |
21/03/2016 | Public releases |